Benitec Biopharma Inc

NASDAQ:BNTC   4:00:00 PM EDT
11.70
+0.35 (+3.08%)
7:19:14 PM EDT: $12.28 +0.58 (+4.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Benitec Biopharma Inc Stock, NASDAQ:BNTC

3940 Trust Way, Hayward, California 94545
United States of America
Phone: +1.510.780.0819
Number of Employees: 16

Description

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.